Heart Failure (HF) is the final and common pathway of all cardiovascular
diseases. Heart Failure: Bench to Bedside helps address a significant
need to develop new paradigms and to identify novel therapeutic targets
for this pervasive disease. An authoritative contribution to the field,
this book provides a detailed description of new findings and emerging
methodologies, as well as a critical clinical evaluation of the complex
HF syndrome and future therapies. Heart Failure: Bench to Bedside
includes a primer on gene profiling and bioenergetics of the normal
heart and a discussion of the molecular, genetic, biochemical and
cellular techniques critical to understanding HF. Further chapters
discuss cardiac remodeling, oxidative stress, and alterations in other
organs and systems that are often associated with HF. This book
thoughtfully evaluates current and forthcoming diagnostic techniques and
therapies, pharmaceutical and pharmacogenomic-based individualized
medicine, gene and cell-based therapies, and the search for new
frontiers. Heart Failure: Bench to Bedside presents a clear view of
up-to-date approaches to clinical diagnosis and treatment, as well as
offering insightful critiques of original and creative scientific
thoughts on post-genomic HF research.